Pietro
Zambonardi

Mid-Level Associate
Ulteriora mirari, praesentia sequi Publio Cornelio Tacito

Pietro carries out his professional activity assisting Italian and foreign clients mainly in legal matters concerning the pharmaceutical, cosmetics, food supplement and medical devices sectors (Life Sciences).

He also assists clients in drafting opinions, negotiating and drafting contracts related to business activities.

Pietro has attended outsourcing programs for pharmaceutical companies focused on assisting day-to-day business.

Pietro joined LCA in February, 2024.
Previously, after a collaboration at the Avvocatura Distrettuale dello Stato in Milan, he worked with Studio Franzosi Dal Negro Setti from 2018 to 2024.

Commercial and corporate Life Sciences

You might also be interested in

05.08.2026
LCA advises Dokicasa’s shareholders on the sale of the remaining 49% stake t ...

The transaction completes the acquisition process launched in 2024

04.08.2026
LCA on the entry into the share capital of WeRoad by an investment vehicle for whi ...

A secondary investment to support WeRoad’s international growth

03.08.2026
LCA in the acquisition of Hydea by Protos (HIG Capital)

The Firm advised the sellers and management in the group’s external growth transaction

03.08.2026
LCA Studio Legale in the acquisition of Istituto Biochimico Italiano G. Lorenzini ...

A strategic operation in ACS Dobfar Group’s vertical integration path

31.07.2026
LCA for the IPO of Dipietro Group S.p.A.

The team followed the admission to trading on Euronext Growth Milan

31.07.2026
LCA Studio Legale advised the lead investors in Aflabox’s seed round

Italian agritech startup detects mycotoxins through UV imaging ...